MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1016/j.ajt.2026.09.018

Медицинская библиотека · American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons · 2026

Progression to Insulin Requirement at One Year After Kidney-Alone Transplantation in Insulin-Independent Type 2 Diabetes: Implications for SPK Candidate Selection.

Ibraheem Mohamed, Isazade Vugar, Zhang Nan, Katariya Nitin K, Kumar Aditi, Heilman Raymond L, Nair Sumi S, Mour Girish K, Kodali Lavanya

СтатьяПеревод в очереди

Аннотация

This single-center retrospective cohort study investigated the incidence and predictors of insulin requirement following kidney transplantation in patients with type 2 diabetes who were insulin-independent at the time of surgery. Eligible patients were aged ≤65 years with BMI ≤30 kg/m2, matching our center's inclusion criteria for simultaneous pancreas-kidney (SPK) transplantation. We analyzed 132 adult recipients transplanted between 2015 and 2023. One-year post-transplantation, 90.9% (120/132) progressed to maintenance insulin therapy, including all patients on oral antidiabetic agents at transplant (n=48). Recipient age, BMI and donor characteristics did not significantly predict progression to insulin therapy. This finding is likely attributable to our stringent inclusion criterion. Pre-transplant HbA1c (mean 6.1%) and c-peptide (mean 9.4 ng/mL) were also similar between groups. Patients requiring insulin had significantly higher one-year glycated hemoglobin than those who remained insulin-free. In a comparison group of 449 kidney transplant recipients without diabetes, the incidence of new-onset diabetes was only 8%. These results indicate that pre-transplant insulin independence in patients with diabetes is a deceptive marker, likely due to altered insulin clearance in end-stage renal disease (ESRD). The near-universal progression to insulin requirement suggests the need to re-evaluate the current selection criteria for SPK transplantation to include this high-risk population, especially those oral hypoglycemic agents whether SPK improves outcomes relative to kidney transplantation with intensive medical therapy in this population remains unestablished.

Для цитирования: Ibraheem Mohamed, Isazade Vugar, Zhang Nan, Katariya Nitin K, Kumar Aditi, Heilman Raymond L, Nair Sumi S, Mour Girish K, Kodali Lavanya. Progression to Insulin Requirement at One Year After Kidney-Alone Transplantation in Insulin-Independent Type 2 Diabetes: Implications for SPK Candidate Selection.. American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons. 2026. DOI: 10.1016/j.ajt.2026.09.018.
Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.